In The News

Stalling on Anti-Corruption in Canada

November 25, 2022
Social Media
Download
Download
Read Mode
Subscribe
Summarize
Sabrina Bandali comments in CBA National magazine on the state of confronting corruption in Canada. She says that foreign bribery case law is thin on the ground in Canada and its scarcity feeds a vicious cycle. With little in the case law to go on, businesses struggle to know precisely what the law requires of them.
 
“When a company notices that something in its operations has gone offside, clearly there are right answers—it should investigate, it should fix the problem,” Sabrina says. “But companies are still faced with a larger uncertainty over what the law requires. And a lack of enforcement leads to that uncertainty. A lot of Canadian companies operating abroad work through third parties. They’re asking themselves, what is the scope of our responsibilities when it comes to these third parties? How far do we need to go to ensure our suppliers aren’t crossing the line? We’ve had anti-corruption laws on the books now for at least 20 years. We should be further along.”
 
Sabrina also comments on how adding a “failure to prevent” offence would expand the suite of options available to combat corruption.
Social Media
Download
Download
Subscribe
Republishing Requests

For permission to republish this or any other publication, contact Erica Wirthlin at wirthline@bennettjones.com.

For informational purposes only

This publication provides an overview of legal trends and updates for informational purposes only. For personalized legal advice, please contact the authors.

Economic Outlook Mid Year 2026
Update

2026 Mid-Year Economic Outlook

May 27, 2026
Serge Dupont
Serge Dupont
The Impact of Global Trade on the Life Sciences Sector
Blog

The Impact of Global Trade on the Life Sciences Sector

May 26, 2026
Alison G. FitzGeraldNasra Moumin
Alison G. FitzGerald & Nasra Moumin
2026 Life Sciences outlook
Update

Life Sciences Outlook 2026

May 26, 2026
Vincent M. de GrandpréMelissa M. Dimilta
Vincent M. de Grandpré & Melissa M. Dimilta
Life Sciences Collaborations and the Risk of Joint Patent Infringement
Blog

Life Sciences Collaborations and the Risk of Joint Patent Infringement

May 26, 2026
Emily P. KettelVincent M. de Grandpré
Emily P. Kettel & Vincent M. de Grandpré